Lipocine (NASDAQ:LPCN) Shares Pass Above 50-Day Moving Average of $6.60

Lipocine Inc. (NASDAQ:LPCN)’s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $6.60 and traded as high as $8.71. Lipocine shares last traded at $7.72, with a volume of 22,285 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Lipocine in a report on Monday, May 13th. They set a “hold” rating for the company.

Lipocine Stock Down 6.3 %

The company has a market capitalization of $41.30 million, a P/E ratio of -4.51 and a beta of 1.12. The company has a 50-day moving average of $6.60 and a two-hundred day moving average of $4.93.

Lipocine (NASDAQ:LPCN) last announced its earnings results on Thursday, May 9th. The specialty pharmaceutical company reported $0.66 earnings per share for the quarter. The business had revenue of $7.62 million for the quarter. As a group, equities analysts expect that Lipocine Inc. will post -1 EPS for the current fiscal year.

About Lipocine

Lipocine Inc, a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.